Leveraging preclinical study designs to close gaps in vaccine development for perinatal pathogens.
Journal Information
Full Title: J Exp Med
Abbreviation: J Exp Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Allergy and Immunology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosures: S.R. Permar serves as a consultant to Merck, Pfizer, Moderna, Dynavax, GSK, and Hoopika CMV vaccine programs and leads sponsored vaccine programs with Moderna and Merck. No other disclosures were reported."
"This work was supported in part by P01AI129859 from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to S.R. Permar."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025